Fetal Nasal Bone Length Nomogram at 11-13wk+6days in Upper NCT04798170

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Not yet recruiting

establish a reference values for the fetal nasal bone length (NBL) in upper egyptian pregnant women at 11-13wk+6 days

By using ultrasound measure fetal nasal bone length at 11-13wk+6days in Upper Egyptian pregnant women in mid-sagittal view in single pregnancy

Recruitment information / eligibility
Status	Not yet recruiting
Enrollment	1
Est. completion date	April 1, 2023
Est. primary completion date	April 1, 2023
Accepts healthy volunteers
Gender	Female
Age group	N/A and older
Eligibility	Inclusion Criteria: Normal antenatal women of gestational age between 11 to 13week +6days. Single pregnancy. Viable fetus. No fetal malformation. No previous history of fetal malformation Exclusion Criteria: Medical diseased women . Multiple gestations . Fetal malformations . Missed abortion .

Other:
• Utrasound
Ultrasound examination

Locations
Country	Name	City	State
n/a

Sponsors *(1)*
Lead Sponsor	Collaborator
Sohag University

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Fetal nasal bone length nomogram	Establish nomogram for nasal bone length in Upper Egyptian pregnant women	2 years